Inhibikase Therapeutics, Inc.

NASDAQ (USD): Inhibikase Therapeutics, Inc. (IKT)

Last Price

3.20

Today's Change

+0.04 (1.26%)

Day's Change

3.07 - 3.50

Trading Volume

1,387,127

Financial

Reported Currency in USD
Show?
Last 10 FY Result (Thousand)
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 261 123 3,101 698 1,123 4,041 2,061 967 -17.05%
PBT -19,029 -18,054 -14,786 -2,848 -5,723 -2,152 -436 -629 62.72%
Tax 0 -149 20 29 25 -161 -405 -15 -
NP -19,029 -17,905 -14,806 -2,877 -5,748 -2,152 -436 -629 62.72%
Tax Rate - - - - - - - - -
Total Cost 19,289 18,029 17,907 3,576 6,871 6,193 2,497 1,596 42.74%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -7,304.75 -14,505.22 -477.52 -411.94 -511.95 -53.27 -21.16 -64.99 96.26%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -3.57 -4.26 -4.88 -1.72 -3.34 -1.61 -0.25 -0.48 33.18%
EPS Diluted -3.57 -4.26 -4.88 -1.72 -3.34 -1.61 -0.25 -0.48 33.18%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment